The CoronaVac vaccine against Covid-19, developed by China's Sinovac Biotech, won emergency use approval by the World Health Organization on Tuesday. Photo: EPA-EFE The CoronaVac vaccine against Covid-19, developed by China's Sinovac Biotech, won emergency use approval by the World Health Organization on Tuesday. Photo: EPA-EFE
The CoronaVac vaccine against Covid-19, developed by China's Sinovac Biotech, won emergency use approval by the World Health Organization on Tuesday. Photo: EPA-EFE

WHO approves Sinovac coronavirus vaccine for emergency use, second Chinese treatment to win designation

  • The company joins Sinopharm as a Chinese supplier endorsed by the World Health Organization
  • The move has the potential to help WHO’s dose-strapped Covax vaccine distribution programme

Topic |   Coronavirus pandemic
The CoronaVac vaccine against Covid-19, developed by China's Sinovac Biotech, won emergency use approval by the World Health Organization on Tuesday. Photo: EPA-EFE The CoronaVac vaccine against Covid-19, developed by China's Sinovac Biotech, won emergency use approval by the World Health Organization on Tuesday. Photo: EPA-EFE
The CoronaVac vaccine against Covid-19, developed by China's Sinovac Biotech, won emergency use approval by the World Health Organization on Tuesday. Photo: EPA-EFE
READ FULL ARTICLE